May 27, 2025 Others
Caution Regarding Suspicious Emails Impersonating the Company
Sumitomo Pharma Co., Ltd. announced that the Company has confirmed the circulation of suspicious emails falsely claiming to be from the Company or its personnel and these suspicious emails are not in any way associated with the Company.
The suspicious emails currently confirmed to be impersonating our company have the following characteristics:
- The sender claims to be a former executive or employee of the Company
- The sender’s email domain does not match the Company’s official domain
- The email includes documents such as purchase orders bearing the Company name, but lists delivery addresses or contact information unrelated to the Company
Below are the official email domain used by the Company’s executives and employees, along with a list of our main offices:
Email domain: 
List
of main offices: https://www.sumitomo-pharma.com/profile/office/
Responding to such emails may result in fraud, information leakage, or virus infection. Please exercise extreme caution. The Company bears no responsibility for any damages caused by these suspicious emails.
If you receive a suspicious email, please do not respond and contact us through the
following
page:
https://www.sumitomo-pharma.com/inquiry/
Inquiries from the Press